EE505 Cost-Effectiveness of Ofatumumab in Treatment of Relapsing Multiple Sclerosis in Turkey

Abstract

Authors

M. Tatar B. Yarcı A.C. Akdemir Ç Ölmez F. İğde E. Tınaz M. Turanlı

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×